Latin American Countries Set Up Joint Procurement Mechanism For Drugs
This article was originally published in SRA
Pharmaceutical companies wanting to sell high cost drugs in Latin America may find themselves talking with multiple countries at once to find a single acceptable price.
You may also be interested in...
Colombian authorities have welcomed savings of 90% for hepatitis C treatments thanks to a pooled procurement initiative supported by the Pan American Health Organization.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
In an exclusive interview with the Pink Sheet, senior NICE director Meindert Boysen reveals the best advice he ever received and how companies whose products are under review can improve their chances of success.